Drug Profile
Pramiconazole
Alternative Names: Azoline; R 126638Latest Information Update: 25 Mar 2010
Price :
$50
*
At a glance
- Originator Johnson & Johnson Pharmaceutical Research & Development
- Developer Stiefel Laboratories
- Class Antifungals; Imidazoles; Triazoles
- Mechanism of Action 14-alpha demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Onychomycosis; Pityriasis versicolor; Tinea corporis; Tinea cruris
Most Recent Events
- 22 Jul 2009 Stiefel Laboratories has been acquired by GlaxoSmithKline
- 05 Feb 2008 Efficacy and adverse events data from a Phase-II trial in Pityriasis versicolor presented at the 66th Annual Meeting of the American Academy of Dermatology (AAD-2008)
- 15 Feb 2007 Preclinical trials in Onychomycosis in Europe (PO)